Istradefylline - CAS 155270-99-8

Istradefylline (KW-6002) (Ki of 2.2 nM) is a selective adenosine A2A receptor (A2AR) antagonist, which is under development in Phase 3 trails. It has been used in trials studying the treatment and basic science of Drug Abuse, Sleep Disorder, Hepatic Impairment, Parkinson's Disease, and Restless Legs Syndrome, among others.

Adenosine Receptor

GPCR/G Protein, Neuroscience

155163

0.9995

C20H24N4O4

384.43

CN1C2=C(N(CC)C(=O)N(CC)C2=O)N=C1/C=C/C3=CC(OC)=C(OC)C=C3

-20°C

Ice Packs

Small Compound